<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29570" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Stroke Center Certification</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Waldman</surname>
            <given-names>Alex</given-names>
          </name>
          <aff>UCF-HCA Consortium- North Florida RMC</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tadi</surname>
            <given-names>Prasanna</given-names>
          </name>
          <aff>Asram Medical College, Eluru, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan Suheb</surname>
            <given-names>Mahammed Z.</given-names>
          </name>
          <aff>University of Wisconsin</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rawal</surname>
            <given-names>Amit R.</given-names>
          </name>
          <aff>University of Central Florida</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alex Waldman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prasanna Tadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mahammed Khan Suheb declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amit Rawal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29570.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Stroke is one of the most significant causes of morbidity and mortality in the United States.<xref ref-type="bibr" rid="article-29570.r1">[1]</xref> Based on data from the Centers for Disease Control and Prevention (CDC), an estimated 795,000 individuals experience acute ischemic strokes (AIS) annually, and at least 150,000 of these cases lead to fatalities.<xref ref-type="bibr" rid="article-29570.r2">[2]</xref>&#x000a0;The economic impact of AIS is significant, with the annual expenses for healthcare services, medications, and missed workdays totaling approximately $34 billion.<xref ref-type="bibr" rid="article-29570.r2">[2]</xref>&#x000a0;Unfortunately, adherence to expert consensus guidelines for treating AIS is not consistently observed, resulting in poorer functional outcomes. In response to this challenge, stroke centers have been established to standardize evidence-based protocols within the inpatient setting and enhance nationwide access to high-quality care.<xref ref-type="bibr" rid="article-29570.r3">[3]</xref></p>
        <p>
<bold>Thrombolytic Therapy in Acute Ischemic Stroke Management</bold>
</p>
        <p>Stroke treatment has undergone significant and rapid advancements in the past 2 to 3 decades, with ongoing research continuing to influence and refine management practices. A critical breakthrough&#x000a0;in stroke therapy occurred in 1996 when the Food and Drug Administration (FDA) approved thrombolytic therapy using alteplase&#x02014;an intravenous (IV) recombinant tissue plasminogen activator (tPA). Although&#x000a0;this treatment has demonstrated remarkable effectiveness for strokes resulting from small vessel occlusions, its efficacy for strokes caused by large vessel occlusions (LVO) has proven to be more limited.<xref ref-type="bibr" rid="article-29570.r4">[4]</xref>&#x000a0;</p>
        <p>Recent studies have examined the standard dose of alteplase, which involves administering 0.9 mg/kg alteplase IV, with a maximum total dose of 90 mg. This dose is given by administering 10% of the total dose as an initial IV bolus over 1 minute, followed by infusing the remainder over 60 minutes. These studies have compared this standard regimen with a rapid infusion of tenecteplase at 0.25 mg/kg. Multiple studies have shown that tenecteplase at both 0.1 and 0.25 mg/kg did not exhibit superiority over alteplase regarding neurological outcomes in patients with AIS within the 3- to 4.5-hour window. However, for patients with LVO, the results did not reach statistical significance.<xref ref-type="bibr" rid="article-29570.r4">[4]</xref><xref ref-type="bibr" rid="article-29570.r5">[5]</xref><xref ref-type="bibr" rid="article-29570.r6">[6]</xref><xref ref-type="bibr" rid="article-29570.r7">[7]</xref>&#x000a0;</p>
        <p>The NEJM Campbell study revealed a statistically significant disparity in achieving greater than 50% reperfusion or unretrievable thrombus during a diagnostic angiogram. The study reported a rate of 22% with tenecteplase compared to 10% with the standard-dose alteplase. Furthermore, the tenecteplase group exhibited superior 90-day functional outcomes compared to the alteplase group. In various studies, meta-analyses have consistently demonstrated either non-inferiority or superior trending results for tenecteplase over alteplase.<xref ref-type="bibr" rid="article-29570.r8">[8]</xref><xref ref-type="bibr" rid="article-29570.r9">[9]</xref><xref ref-type="bibr" rid="article-29570.r10">[10]</xref>&#x000a0;</p>
        <p>In terms of safety, research findings have been somewhat varied, with some studies indicating a tendency toward fewer intracranial bleeding complications with low-dose tenecteplase (0.1 or 0.25 mg/kg) compared to high-dose tenecteplase (0.4 mg/kg) and standard-dose alteplase. A larger&#x000a0;randomized controlled trial with a higher statistical power&#x000a0;could provide valuable insights into the efficacy and safety profiles of&#x000a0;tenecteplase compared to alteplase in LVO patients eligible for embolectomy.</p>
        <p>Ideally, conducting studies at various time frames, such as 3 hours, 4.5 hours, 6 hours, and 6 to 24 hours before mechanical thrombectomy (MT), could offer valuable insights into whether tenecteplase exhibits superiority in cases of LVO. Further research will be&#x000a0;necessary to determine whether tenecteplase can be more effective in treating AIS with LVO within 4.5 to 24 hours or in cases of early wake-up strokes.</p>
        <p>The TIMELESS study is currently in progress and aims to evaluate the safety and efficacy of tenecteplase in patients eligible for imaging and those within the late-time window. The study reached its conclusion on November 30, 2021.<xref ref-type="bibr" rid="article-29570.r11">[11]</xref></p>
        <p>
<bold>Embolectomy Therapy in&#x000a0;DNV-GL<bold>Acute Ischemic Stroke</bold> Management</bold>
</p>
        <p>LVO strokes are traditionally recognized as the most devastating in terms of morbidity and mortality.&#x000a0;However, over the past 10 to 20 years, embolectomy or MT has significantly improved survival rates and functional outcomes for individuals with LVO strokes.<xref ref-type="bibr" rid="article-29570.r12">[12]</xref><xref ref-type="bibr" rid="article-29570.r13">[13]</xref><xref ref-type="bibr" rid="article-29570.r14">[14]</xref><xref ref-type="bibr" rid="article-29570.r15">[15]</xref>&#x000a0;These groundbreaking therapies have revolutionized modern stroke care, establishing a new LVO treatment standard.</p>
        <p>The&#x000a0;implementation of MT brought about a shift in the stroke center certification classification, now mandating facilities to have the capability to perform this life-saving procedure.<xref ref-type="bibr" rid="article-29570.r16">[16]</xref><xref ref-type="bibr" rid="article-29570.r17">[17]</xref><xref ref-type="bibr" rid="article-29570.r18">[18]</xref><xref ref-type="bibr" rid="article-29570.r19">[19]</xref>&#x000a0;The adage "time is the brain" emphasizes the critical importance of timely intervention. Earlier tPA administration is associated with improved functional outcomes, reduced intracranial bleeding risk, and lower hospital mortality rates. A mere 15-minute delay in tPA initiation is associated with a decline in the likelihood of achieving functional independence, surviving until discharge, accessing rehabilitation, and avoiding symptomatic intracranial bleeding. The odds of these outcomes decrease by 3% to 4% for every 15-minute delay interval.<xref ref-type="bibr" rid="article-29570.r20">[20]</xref>&#x000a0;For LVO strokes, early intervention is critical for patients undergoing MT. Each additional hour of delay in achieving MT reperfusion is associated with reduced functional independence, increased morbidity, and a diminished quality of life.<xref ref-type="bibr" rid="article-29570.r21">[21]</xref></p>
        <p>According to the most recent guidelines released by the American Stroke Association (ASA) in 2018, eligible patients are advised to receive IV tPA as soon as possible, ideally within 3 hours of their last known normal state. In certain cases, selected patient groups may be considered for an extended time window of up to 4.5 hours. For eligible LVO patients, it is recommended to undergo MT as soon as possible, ideally within 6 to 16 hours from their last known normal. However, in certain cases, MT may still be a viable option within a broader time frame of up to 24 hours from the last known normal.<xref ref-type="bibr" rid="article-29570.r1">[1]</xref>&#x000a0;Given these recommendations, healthcare&#x000a0;practitioners must be well-informed about stroke center accreditation levels and capabilities&#x000a0;to initiate timely and appropriate treatment.</p>
      </sec>
      <sec id="article-29570.s2" sec-type="Function">
        <title>Function</title>
        <p>Stroke&#x000a0;centers were&#x000a0;established following the publication of a consensus statement in the <italic toggle="yes">Journal of the American Medical Association</italic> in 2000. The Brain Attack Coalition (BAC), a collaboration of multiple professional stroke societies and regulatory agencies, played a pivotal role in shaping this groundbreaking consensus on stroke care. With the evolving landscape of medical treatment for stroke, additional consensus statements have been released. These statements have outlined the necessity for various types of stroke centers and have further defined their distinct capabilities and levels of treatment.</p>
        <p>Stroke centers are established to improve&#x000a0;the quality and coordination of acute stroke care. Certifying organizations possess the authority to reward designated facilities&#x000a0;that adhere to&#x000a0;evidence-based guidelines and&#x000a0;can provide varying levels of care, ranging from&#x000a0;fundamental to advanced stroke&#x000a0;care. Several organizations, such as The Joint Commission (TJC), the Healthcare Facilities Accreditation Program (HFAP), Det Norske Veritas, Inc (DNV), and the Center for Improvement in&#x000a0;Healthcare&#x000a0;Quality (CHIQ), are involved in the certification process. These&#x000a0;agencies assess various&#x000a0;outcome measures, including healthcare team experience, patient volume, research initiatives, and survey frequency.</p>
        <p>
<bold>Stroke Center Classification</bold>
</p>
        <p>The most basic level of stroke center certification is the acute stroke-ready hospital (ASRH). These hospitals are equipped to perform rapid clinical stroke assessments, provide stabilization, and implement protocols for the safe administration of tPA. ASRHs are typically located in regions where primary stroke centers (PSCs) are not readily accessible. Upon the conclusion of the initial assessment and stabilization, patients are usually transferred to a more advanced stroke center for further evaluation and advanced diagnostic procedures. The establishment of ASRHs has significantly expanded the accessibility of initial stroke care in areas with limited resources, facilitating the seamless integration of patients into the broader stroke care system.<xref ref-type="bibr" rid="article-29570.r22">[22]</xref>&#x000a0;</p>
        <p>The ASRH's primary objective is to acknowledge hospitals that provide timely, evidence-based care to stroke patients before transferring them&#x000a0;to a PSC or comprehensive stroke center (CSC).<xref ref-type="bibr" rid="article-29570.r22">[22]</xref> ASRH certification is granted to eligible hospitals for a 2-year period following an on-site review. Organizations seeking this certification must meet specific requirements as outlined by TJC's Disease-Specific Care Certification program, which include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Maintaining a dedicated stroke-focused program.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Staffing by qualified medical professionals specifically trained in stroke care.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Collaborating with local Emergency&#x000a0;Medical&#x000a0;Services (EMS) to encourage training in field assessment tools and communication with the hospital&#x000a0;before transporting stroke patients.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Maintaining the capability for rapid diagnostic and laboratory testing around the clock, 24/7.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Having the ability to administer IV clot-busting medications to eligible patients.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Incorporating telemedicine technology into their services.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Establishing transfer agreements or protocols with facilities that offer PSC or CSC.<xref ref-type="bibr" rid="article-29570.r22">[22]</xref></p>
          </list-item>
        </list>
        <p>PSCs&#x000a0;represent the next level of stroke center certification, which includes a dedicated interdisciplinary stroke team, access to advanced cerebrovascular imaging, and an inpatient stroke unit designed for the admission and care of patients with an AIS.<xref ref-type="bibr" rid="article-29570.r23">[23]</xref><xref ref-type="bibr" rid="article-29570.r24">[24]</xref>&#x000a0;</p>
        <p>The PSC certification recognizes hospitals that&#x000a0;adhere to specific standards designed to enhance stroke care and improve patient outcomes. These standards encompass a range of critical elements, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Establishing a dedicated stroke-focused program.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ensuring staffing by qualified medical professionals specifically trained in stroke care.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Providing individualized care tailored to meet the unique needs of stroke patients.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Promoting patient involvement in their hospital care.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Facilitating the coordination of post-discharge patient self-care.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ensuring a streamlined flow of patient information while protecting patient rights, security, and privacy.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Collecting and maintaining the hospital's stroke-treatment performance data.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Maintaining data on hospital team performance.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Utilizing data to evaluate and continually enhance the quality of care.</p>
          </list-item>
        </list>
        <p>The third level of stroke centers is referred to as thrombectomy-capable stroke centers (TSC). These institutions can provide 24/7 care for AIS patients and are equipped with an on-call neurovascular and neuro-interventional team and a dedicated neurological intensive care unit (ICU). The primary focus of TSCs is to provide MT for eligible patients, even if they may not meet all the criteria of CSCs. These TSCs receive certification from TJC, with the initial certifications commencing in 2018.</p>
        <p>For a facility to be&#x000a0;designated as a TSC, it must perform a specified minimum number of MT each year.&#x000a0;TSCs are designed to ensure all the capabilities of PSCs while additionally possessing the capacity to deliver high-quality endovascular&#x000a0;thrombectomy (EVT) and post-EVT care. In addition to their ability to perform MT, TSCs are required to establish transfer agreements with CSCs. These agreements facilitate the swift transfer of patients who encounter intracranial hemorrhages or present with cases that surpass the resources available at the TSC.</p>
        <p>Although TSCs can provide MT, CSCs remain the preferred destination for patients with suspected LVO as determined by EMS triage. This preference is due to the limitations of clinical prediction rules for identifying LVOs in the field, which have limited sensitivity and specificity for identifying LVOS.<xref ref-type="bibr" rid="article-29570.r25">[25]</xref>&#x000a0;The development of TSCs exemplifies the agility and adaptability of stroke center frameworks.<xref ref-type="bibr" rid="article-29570.r26">[26]</xref>&#x000a0;These centers&#x000a0;have&#x000a0;neurointensive care units and maintain 24/7 on-site critical care coverage.</p>
        <p>The CSC represents the highest level of stroke care, providing a comprehensive team of experts, including vascular neurologists, neurosurgeons, and vascular surgeons. The CSC Certification acknowledges hospitals that meet&#x000a0;rigorous standards to&#x000a0;deliver specialized care for the most complex stroke cases.</p>
        <p>In addition to satisfying all the prerequisites for a PSC certification, CSCs must fulfill the following additional standards:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>The availability of advanced imaging techniques, including magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), computed tomographic angiography (CTA),&#x000a0;digital subtraction angiography (DSA), and transcranial Doppler (TCD) ultrasound.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A team of personnel trained in vascular neurology, neurosurgery, and endovascular procedures.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Round-the-clock accessibility to personnel, imaging, operating rooms, and endovascular facilities.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The presence of ICU and neuroscience ICU facilities and the corresponding capabilities.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A wealth of experience and expertise in treating patients with large ischemic strokes, intracerebral hemorrhage (ICH), and subarachnoid hemorrhage.<xref ref-type="bibr" rid="article-29570.r27">[27]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29570.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>An ongoing debate and research in stroke care pertains to the most effective prehospital strategy for transferring stroke patients to the most appropriate stroke-certified center. The efficient and timely transportation and well-coordinated treatment protocols from lower- to higher-level stroke centers have significantly curtailed the administration times for tPA and MT procedures. A patient identified by EMS as having a stroke and located 15 minutes away from the nearest&#x000a0;ASRH or PSC, and&#x000a0;30 minutes away from the closest TSC or CSC, may face a decision: which center should they choose for care?</p>
        <p>Currently, 2 common routing strategies exist&#x02014; the "drip-and-ship" and "mothership."</p>
        <p>
<bold>The Drip-and-Ship Strategy</bold>
</p>
        <p>Drip-and-ship is a prehospital transport strategy that entails the initial transportation of a stroke patient to the nearest stroke center, which may be an ASRH or PSC. The principal objective of this approach is to promptly initiate IV tPA for eligible patients who meet the criteria for such intervention.</p>
        <p>Upon reaching the nearest stroke center, the patient undergoes rapid assessment and diagnostic imaging to ascertain the suitability for tPA administration. If advanced imaging identifies an LVO amenable to MT, the patient is transferred to a more distant TSC or CSC for specialized intervention.</p>
        <p>The advantage of the drip-and-ship strategy lies in the swift initiation of IV tPA, which is critical for improving outcomes in certain stroke patients. Initiating tPA promptly at the nearest stroke center mitigates the risk of delays in thrombolytic treatment, potentially resulting in improved outcomes for patients who are candidates for this therapy.</p>
        <p>In their research, Sheth and colleagues examined data from a substantial cohort of 44,667 patients who experienced ischemic strokes and received intravenous tPA treatment within 3 hours of symptom onset.<xref ref-type="bibr" rid="article-29570.r28">[28]</xref>&#x000a0;These data were sourced from the Get With The Guidelines-Stroke program, encompassing the period from April 2003 to October 2010 and involving 1440 hospitals.&#x000a0;The study findings revealed that approximately 1 in 4 AIS patients who received tPA were treated through the drip-and-ship strategy. The outcomes for patients following this approach exhibited modest differences compared&#x000a0;to those&#x000a0;who were directly admitted to a stroke center and received tPA.<xref ref-type="bibr" rid="article-29570.r29">[29]</xref></p>
        <p>
<bold>The Mothership or Bypass Strategy</bold>
</p>
        <p>Mothership is a prehospital transport strategy that bypasses closer&#x000a0;ASRHs or PSCs and&#x000a0;directly transports the stroke patient to a TSC or CSC. The primary objective of this approach is to expedite the evaluation and potential&#x000a0;MT for patients with&#x000a0;AIS resulting from&#x000a0;LVO.</p>
        <p>The eligibility for MT is limited to patients with AIS caused by LVO. Hence, the "mothership" strategy is considered more reasonable if EMS can accurately recognize LVO cases in the field before making a hospital destination decision. To assist in identifying potential LVOs, EMS personnel utilize various stroke scales designed for prehospital detection. These screening tools&#x000a0;include the Los Angeles Motor Scale (LAMS),<xref ref-type="bibr" rid="article-29570.r30">[30]</xref>&#x000a0;Cincinnati Prehospital Stroke Severity Scale (CSTAT),<xref ref-type="bibr" rid="article-29570.r31">[31]</xref>&#x000a0;Rapid Arterial Occlusion Evaluation (RACE),<xref ref-type="bibr" rid="article-29570.r32">[32]</xref>&#x000a0;and Field Assessment Stroke Triage for Emergency Destination (FAST-ED).<xref ref-type="bibr" rid="article-29570.r33">[33]</xref> Selecting a particular&#x000a0;screening tool&#x000a0;often depends on regional stroke system preferences and the available resources.</p>
        <p>In their meta-analyses and systematic review, Romoli et al examined data from patients with&#x000a0;AIS who were eligible for reperfusion strategies. The mothership paradigm was associated with higher rates of functional independence at&#x000a0;3 months compared to the drip-and-ship strategy.<xref ref-type="bibr" rid="article-29570.r34">[34]</xref></p>
        <p>The RACECAT randomized clinical trial addressed the critical issue of optimal prehospital triage for&#x000a0;AIS patients. The trial's findings demonstrated a non-superiority or potential inferiority of the strategy that involved redirecting all LVO-suspected patients to the endovascular thrombectomy-capable stroke center (EVT-SC). This suggests that there was no distinct advantage in bypassing PSCs for EVT-SCs for all cases suspected of having LVO. Furthermore, although the findings were not statistically significant, the trend toward increased mortality among ICH patients within the EVT-SC group underscores that a particular subset of acute stroke patients might benefit from early triage at PSCs. For example, this could facilitate quicker blood pressure control and the rapid reversal of coagulopathic conditions.<xref ref-type="bibr" rid="article-29570.r35">[35]</xref></p>
        <p>
<bold>Strategy Algorithm&#x000a0;</bold>
</p>
        <p>The 2018 American Heart Association (AHA) and ASA guidelines state, "It remains unknown whether it would be beneficial for&#x000a0;EMS to bypass a closer IV tPA-capable hospital for a thrombectomy-capable hospital."&#x000a0;<xref ref-type="bibr" rid="article-29570.r1">[1]</xref></p>
        <p>To address this uncertainty, the AHA and ASA have put forward an EMS triage algorithm to aid in decision-making. According to this algorithm, patients with suspected LVO and a last known normal time within 6 hours should be transported directly to the nearest TSC or CSC, as long as this bypass does not extend the transport time by more than 15 minutes and does not preclude the administration of IV tPA.</p>
        <p>Future recommendations regarding prehospital triage will likely be influenced by ongoing research&#x000a0;and studies investigating patient outcomes, the efficiency of field assessment tools for LVO identification, and the evaluation of regional healthcare resources.<xref ref-type="bibr" rid="article-29570.r1">[1]</xref></p>
        <p>Additional concerns in stroke care encompass the need for comprehensive training of emergency department (ED) and hospital-based healthcare providers to&#x000a0;keep up with&#x000a0;the rapidly evolving&#x000a0;stroke recommendations. Traditionally, providers may have&#x000a0;primarily focused on&#x000a0;evaluating&#x000a0;an AIS patient for IV tPA eligibility. However, current guidelines underscore the significance of acquiring advanced multimodal neurovascular imaging to detect potential LVO and swiftly transferring&#x000a0;suitably triaged patients to a TSC- or CSC-certified stroke center for potential MT.</p>
      </sec>
      <sec id="article-29570.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Stroke remains a leading cause of morbidity, mortality, and healthcare expense in the United States. The burden of stroke is on the rise despite remarkable advancements in evidence-based acute care treatments and significant modifications in acute care stroke systems, procedures, and quality standards.&#x000a0;</p>
        <p>Therapeutic approaches have been rapidly advancing in recent years, even for the most severe strokes. A comprehensive understanding of the specific stroke guidelines and the corresponding stroke center certifications is crucial in ensuring appropriate patient&#x000a0;care and destination protocols. Timely recognition of stroke symptoms is paramount, as any delays in treatment can result in less favorable outcomes and could disqualify patients from vital medications or interventions capable of influencing the progression of their condition.<xref ref-type="bibr" rid="article-29570.r15">[15]</xref></p>
      </sec>
      <sec id="article-29570.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>The lack of standardization&#x000a0;in stroke center certification is a&#x000a0;valid&#x000a0;concern that warrants attention.<xref ref-type="bibr" rid="article-29570.r23">[23]</xref>&#x000a0;Stroke centers can attain&#x000a0;certification&#x000a0;through various independent organizations such as TJC, DNV, and HFAP. Government agencies may also grant stroke center designations in certain regions, while some institutions opt for self-certification. The&#x000a0;BAC strongly&#x000a0;advocates for independent certification, a more accurate, rigorous, and comprehensive process for assessing stroke centers.<xref ref-type="bibr" rid="article-29570.r23">[23]</xref></p>
        <p>A study&#x000a0;investigating&#x000a0;the quality of care and outcomes in PSCs&#x000a0;participating&#x000a0;in the "Get With The Guidelines" stroke data comparison&#x000a0;identified statistically significant&#x000a0;variations between certification organizations. Specifically, the study observed that the rate of IV tPA use was higher in PSCs certified by TJC and DNV, whereas it was lower in HFAP- and state-certified hospitals. Furthermore, compared to others, door-to-needle times were extended in hospitals certified by HFAP. In addition, state-certified PSCs had a higher in-hospital mortality rate.<xref ref-type="bibr" rid="article-29570.r36">[36]</xref></p>
        <p>To address this issue, it may be essential for certification organizations and regulatory bodies to collaborate and establish unified guidelines and quality metrics for stroke care certification. By adopting standardized performance measures, stroke centers can be held to consistent and evidence-based benchmarks, thereby improving stroke care and ultimately resulting in improved patient outcomes.</p>
      </sec>
      <sec id="article-29570.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Optimal stroke care relies on seamless coordination and effective communication among healthcare&#x000a0;practitioners at all levels of the healthcare system. This collaborative approach commences with the initial contact of EMS with the patient and persists throughout the evaluation and treatment process. This&#x000a0;involves a multidisciplinary stroke team encompassing clinicians, pharmacists, and nurses when the patient arrives at the hospital.&#x000a0;The&#x000a0;radiology department plays a crucial role in providing timely imaging. In some instances, acute surgical or endovascular interventions may be necessary, followed by inpatient and outpatient rehabilitation to support the patient's recovery.&#x000a0;</p>
        <p>Efficient teamwork is fundamental for effective stroke therapy, as time-sensitive interventions are essential in stroke management. The entire stroke network, including EMS, hospital staff, and rehabilitation teams, must operate seamlessly to provide rapid identification and implementation of appropriate care. Early recognition of stroke symptoms and prompt communication among all components of the stroke care system are critical factors in improving patient outcomes.</p>
      </sec>
      <sec id="article-29570.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29570&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29570">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29570/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29570">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29570.s8">
        <title>References</title>
        <ref id="article-29570.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powers</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Rabinstein</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ackerson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Adeoye</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Bambakidis</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Biller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Demaerschalk</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Hoh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jauch</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Kidwell</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Leslie-Mazwi</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Ovbiagele</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sheth</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Southerland</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Summers</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Tirschwell</surname>
                <given-names>DL</given-names>
              </name>
              <collab>American Heart Association Stroke Council</collab>
            </person-group>
            <article-title>2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.</article-title>
            <source>Stroke</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>e46</fpage>
            <page-range>e46-e110</page-range>
            <pub-id pub-id-type="pmid">29367334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roger</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Go</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Carnethon</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Simone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Fullerton</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Greenlund</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hailpern</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Heit</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Kissela</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Kittner</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lichtman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lisabeth</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Makuc</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Marelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matchar</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Meigs</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mozaffarian</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mussolino</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Paynter</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Stafford</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Wylie-Rosett</surname>
                <given-names>J</given-names>
              </name>
              <collab>American Heart Association Statistics Committee and Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart disease and stroke statistics--2011 update: a report from the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2011</year>
            <month>Feb</month>
            <day>01</day>
            <volume>123</volume>
            <issue>4</issue>
            <fpage>e18</fpage>
            <page-range>e18-e209</page-range>
            <pub-id pub-id-type="pmid">21160056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duncan</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Bushnell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sissine</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lutz</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Radman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pvru Bettger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zorowitz</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive Stroke Care and Outcomes: Time for a Paradigm Shift.</article-title>
            <source>Stroke</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>385</fpage>
            <page-range>385-393</page-range>
            <pub-id pub-id-type="pmid">33349012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cheripelli</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kalladka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moreton</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Muir</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.</article-title>
            <source>Lancet Neurol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>368</fpage>
            <page-range>368-76</page-range>
            <pub-id pub-id-type="pmid">25726502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campbell</surname>
                <given-names>BCV</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Churilov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yassi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kleinig</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Dowling</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bush</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dewey</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Thijs</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Scroop</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asadi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Wijeratne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Miteff</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Salvaris</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garcia-Esperon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Villiers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Redmond</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leggett</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Collecutt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coulthard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Clouston</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mahady</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Phan</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Slater</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harrington</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Faulder</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Steinfort</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Bladin</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Donnan</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SM</given-names>
              </name>
              <collab>EXTEND-IA TNK Investigators</collab>
            </person-group>
            <article-title>Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Apr</month>
            <day>26</day>
            <volume>378</volume>
            <issue>17</issue>
            <fpage>1573</fpage>
            <page-range>1573-1582</page-range>
            <pub-id pub-id-type="pmid">29694815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haley</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Grotta</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lyden</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Hemmen</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Fanale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Libman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kwiatkowski</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Llinas</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Buchsbaum</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>B</given-names>
              </name>
              <collab>Tenecteplase in Stroke Investigators</collab>
            </person-group>
            <article-title>Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial.</article-title>
            <source>Stroke</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>707</fpage>
            <page-range>707-11</page-range>
            <pub-id pub-id-type="pmid">20185783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Logallo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Novotny</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Assmus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kvistad</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Alteheld</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>R&#x000f8;nning</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Thommessen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Amthor</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Ihle-Hansen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kurz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tobro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stankiewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlsson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morsund</surname>
                <given-names>&#x000c5;</given-names>
              </name>
              <name>
                <surname>Idicula</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aamodt</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>N&#x000e6;ss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Waje-Andreassen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Thomassen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.</article-title>
            <source>Lancet Neurol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>10</issue>
            <fpage>781</fpage>
            <page-range>781-788</page-range>
            <pub-id pub-id-type="pmid">28780236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thelengana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>359</fpage>
            <page-range>359-367</page-range>
            <pub-id pub-id-type="pmid">29728903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheiri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Osman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abdalla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haykal</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bachuwa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Al Qasmi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.</article-title>
            <source>J Thromb Thrombolysis</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>440</fpage>
            <page-range>440-450</page-range>
            <pub-id pub-id-type="pmid">30117036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burgos</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.</article-title>
            <source>Stroke</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>8</issue>
            <fpage>2156</fpage>
            <page-range>2156-2162</page-range>
            <pub-id pub-id-type="pmid">31318627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albers</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Lansberg</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Butcher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Froehler</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Schwamm</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Nouh</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Liebeskind</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Toy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Massaro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schoeffler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Purdon</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design.</article-title>
            <source>Int J Stroke</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-241</page-range>
            <pub-id pub-id-type="pmid">35262424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berkhemer</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Fransen</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Beumer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Lingsma</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schonewille</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Vos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nederkoorn</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Wermer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>van Walderveen</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Staals</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hofmeijer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Oostayen</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lycklama &#x000e0; Nijeholt</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Boiten</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Emmer</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>de Bruijn</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kappelle</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Kort</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>van Rooij</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>van Hasselt</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Aerden</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Dallinga</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bot</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Vroomen</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Eshghi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schreuder</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Heijboer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Keizer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tielbeek</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>den Hertog</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Gerrits</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>van den Berg-Vos</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Karas</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Steyerberg</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Flach</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Marquering</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Sprengers</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Jenniskens</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Beenen</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Koudstaal</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>van Zwam</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Roos</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>van der Lugt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Oostenbrugge</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Majoie</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Dippel</surname>
                <given-names>DW</given-names>
              </name>
              <collab>MR CLEAN Investigators</collab>
            </person-group>
            <article-title>A randomized trial of intraarterial treatment for acute ischemic stroke.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Jan</month>
            <day>01</day>
            <volume>372</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-20</page-range>
            <pub-id pub-id-type="pmid">25517348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goyal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Demchuk</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Eesa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rempel</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Thornton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jovin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Willinsky</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sapkota</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Dowlatshahi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Frei</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Kamal</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Montanera</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Poppe</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Ryckborst</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Shuaib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tampieri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>OY</given-names>
              </name>
              <name>
                <surname>Baxter</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Heo</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Holmstedt</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Jankowitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Linares</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mandzia</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Swartz</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Coutts</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Morrish</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Weill</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Subramaniam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mitha</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lowerison</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Sajobi</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>MD</given-names>
              </name>
              <collab>ESCAPE Trial Investigators</collab>
            </person-group>
            <article-title>Randomized assessment of rapid endovascular treatment of ischemic stroke.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>12</day>
            <volume>372</volume>
            <issue>11</issue>
            <fpage>1019</fpage>
            <page-range>1019-30</page-range>
            <pub-id pub-id-type="pmid">25671798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campbell</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kleinig</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Dewey</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Churilov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yassi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dowling</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Oxley</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Miteff</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harrington</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Faulder</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Steinfort</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Priglinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Scroop</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>McGuinness</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wijeratne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Phan</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Bladin</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Badve</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Villiers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Donnan</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SM</given-names>
              </name>
              <collab>EXTEND-IA Investigators</collab>
            </person-group>
            <article-title>Endovascular therapy for ischemic stroke with perfusion-imaging selection.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>12</day>
            <volume>372</volume>
            <issue>11</issue>
            <fpage>1009</fpage>
            <page-range>1009-18</page-range>
            <pub-id pub-id-type="pmid">25671797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jovin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Chamorro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cobo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Miquel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Rovira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>San Rom&#x000e1;n</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Serena</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abilleira</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rib&#x000f3;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mill&#x000e1;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Urra</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cardona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Cancio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tomasello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casta&#x000f1;o</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blasco</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aja</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dorado</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Quesada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rubiera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hernandez-P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Demchuk</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>von Kummer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gallofr&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D&#x000e1;valos</surname>
                <given-names>A</given-names>
              </name>
              <collab>REVASCAT Trial Investigators</collab>
            </person-group>
            <article-title>Thrombectomy within 8 hours after symptom onset in ischemic stroke.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Jun</month>
            <day>11</day>
            <volume>372</volume>
            <issue>24</issue>
            <fpage>2296</fpage>
            <page-range>2296-306</page-range>
            <pub-id pub-id-type="pmid">25882510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonafe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Albers</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Cognard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Hacke</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jovin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Mattle</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Yavagal</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Baxter</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Devlin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>du Mesnil de Rochemont</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Jahan</surname>
                <given-names>R</given-names>
              </name>
              <collab>SWIFT PRIME Investigators</collab>
            </person-group>
            <article-title>Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Jun</month>
            <day>11</day>
            <volume>372</volume>
            <issue>24</issue>
            <fpage>2285</fpage>
            <page-range>2285-95</page-range>
            <pub-id pub-id-type="pmid">25882376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bracard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ducrocq</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Mas</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Soudant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oppenheim</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moulin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Guillemin</surname>
                <given-names>F</given-names>
              </name>
              <collab>THRACE investigators</collab>
            </person-group>
            <article-title>Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.</article-title>
            <source>Lancet Neurol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>1138</fpage>
            <page-range>1138-47</page-range>
            <pub-id pub-id-type="pmid">27567239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nogueira</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Jadhav</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Haussen</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Bonafe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Budzik</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Bhuva</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yavagal</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Ribo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cognard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hanel</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sila</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Millan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>English</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>QA</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Baxter</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Cardona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Veznedaroglu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hellinger</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kirmani</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Jankowitz</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Frankel</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Costalat</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vora</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Furlan</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Rubiera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aghaebrahim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Olivot</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Tekle</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Graves</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Liebeskind</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Jovin</surname>
                <given-names>TG</given-names>
              </name>
              <collab>DAWN Trial Investigators</collab>
            </person-group>
            <article-title>Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Jan</month>
            <day>04</day>
            <volume>378</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-21</page-range>
            <pub-id pub-id-type="pmid">29129157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albers</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Kemp</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ortega-Gutierrez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McTaggart</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Torbey</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Kim-Tenser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leslie-Mazwi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sarraj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kasner</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Yeatts</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mlynash</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heit</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Zaharchuk</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carrozzella</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palesch</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Demchuk</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bammer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lavori</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lansberg</surname>
                <given-names>MG</given-names>
              </name>
              <collab>DEFUSE 3 Investigators</collab>
            </person-group>
            <article-title>Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Feb</month>
            <day>22</day>
            <volume>378</volume>
            <issue>8</issue>
            <fpage>708</fpage>
            <page-range>708-718</page-range>
            <pub-id pub-id-type="pmid">29364767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Grau-Sepulveda</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Schwamm</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.</article-title>
            <source>JAMA</source>
            <year>2013</year>
            <month>Jun</month>
            <day>19</day>
            <volume>309</volume>
            <issue>23</issue>
            <fpage>2480</fpage>
            <page-range>2480-8</page-range>
            <pub-id pub-id-type="pmid">23780461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van der Lugt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Majoie</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Dippel</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Demchuk</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tomasello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cardona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Devlin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Frei</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>du Mesnil de Rochemont</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Berkhemer</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Jovin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>van Zwam</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Casta&#x000f1;o</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sapkota</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Fransen</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>van Oostenbrugge</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Chamorro</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Lingsma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Donnan</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Shuaib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stouch</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Davalos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roos</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>MD</given-names>
              </name>
              <collab>HERMES Collaborators</collab>
            </person-group>
            <article-title>Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Sep</month>
            <day>27</day>
            <volume>316</volume>
            <issue>12</issue>
            <fpage>1279</fpage>
            <page-range>1279-88</page-range>
            <pub-id pub-id-type="pmid">27673305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alberts</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Latchaw</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Crocco</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Baranski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bass</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ruff</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gress</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Emr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Formation and function of acute stroke-ready hospitals within a stroke system of care recommendations from the brain attack coalition.</article-title>
            <source>Stroke</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>44</volume>
            <issue>12</issue>
            <fpage>3382</fpage>
            <page-range>3382-93</page-range>
            <pub-id pub-id-type="pmid">24222046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alberts</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Hademenos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Latchaw</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Jagoda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marler</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mayberg</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Starke</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Viste</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Girgus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shephard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Emr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shwayder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.</article-title>
            <source>JAMA</source>
            <year>2000</year>
            <month>Jun</month>
            <day>21</day>
            <volume>283</volume>
            <issue>23</issue>
            <fpage>3102</fpage>
            <page-range>3102-9</page-range>
            <pub-id pub-id-type="pmid">10865305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alberts</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Latchaw</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Jagoda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Crocco</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prudhomme</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gress</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bass</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ruff</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Foell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Armonda</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Emr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baranski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MD</given-names>
              </name>
              <collab>Brain Attack Coalition</collab>
            </person-group>
            <article-title>Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition.</article-title>
            <source>Stroke</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>9</issue>
            <fpage>2651</fpage>
            <page-range>2651-65</page-range>
            <pub-id pub-id-type="pmid">21868727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>FO</given-names>
              </name>
              <name>
                <surname>Mont'Alverne</surname>
                <given-names>FJA</given-names>
              </name>
              <name>
                <surname>Bandeira</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Pre-hospital Assessment of Large Vessel Occlusion Strokes: Implications for Modeling and Planning Stroke Systems of Care.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>955</fpage>
            <pub-id pub-id-type="pmid">31572286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baker</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Tschurtz</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Aliaga</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Jauch</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Schwamm</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Determining the Need for Thrombectomy-Capable Stroke Centers Based on Travel Time to the Nearest Comprehensive Stroke Center.</article-title>
            <source>Jt Comm J Qual Patient Saf</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>46</volume>
            <issue>9</issue>
            <fpage>501</fpage>
            <page-range>501-505</page-range>
            <pub-id pub-id-type="pmid">32736996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alberts</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Latchaw</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Selman</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Shephard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hadley</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Brass</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Koroshetz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Marler</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Booss</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zorowitz</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Croft</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Magnis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mulligan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jagoda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cawley</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Connors</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rose-DeRenzy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Emr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MD</given-names>
              </name>
              <collab>Brain Attack Coalition</collab>
            </person-group>
            <article-title>Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition.</article-title>
            <source>Stroke</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>1597</fpage>
            <page-range>1597-616</page-range>
            <pub-id pub-id-type="pmid">15961715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheth</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Grau-Sepulveda</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Kleindorfer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Schwamm</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes.</article-title>
            <source>Stroke</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>732</fpage>
            <page-range>732-9</page-range>
            <pub-id pub-id-type="pmid">25672784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deguchi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mizuno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kohyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tanahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takao</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.</article-title>
            <source>J Stroke Cerebrovasc Dis</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-67</page-range>
            <pub-id pub-id-type="pmid">28867523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Llanes</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Kidwell</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Starkman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leary</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field.</article-title>
            <source>Prehosp Emerg Care</source>
            <year>2004</year>
            <season>Jan-Mar</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-50</page-range>
            <pub-id pub-id-type="pmid">14691787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>McMullan</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Sucharew</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Adeoye</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Design and validation of a prehospital scale to predict stroke severity: Cincinnati Prehospital Stroke Severity Scale.</article-title>
            <source>Stroke</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>1508</fpage>
            <page-range>1508-12</page-range>
            <pub-id pub-id-type="pmid">25899242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez de la Ossa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Carrera</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gorchs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Querol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mill&#x000e1;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gomis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dorado</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Cancio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chicharro</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Escalada</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>D&#x000e1;valos</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale.</article-title>
            <source>Stroke</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-91</page-range>
            <pub-id pub-id-type="pmid">24281224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>FO</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Furie</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Frankel</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lev</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>&#x000c9;C</given-names>
              </name>
              <name>
                <surname>Haussen</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Singhal</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Koroshetz</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Field Assessment Stroke Triage for Emergency Destination: A Simple and Accurate Prehospital Scale to Detect Large Vessel Occlusion Strokes.</article-title>
            <source>Stroke</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>47</volume>
            <issue>8</issue>
            <fpage>1997</fpage>
            <page-range>1997-2002</page-range>
            <pub-id pub-id-type="pmid">27364531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romoli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Paciaroni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsivgoulis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Agostoni</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Vidale</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mothership versus Drip-and-Ship Model for Mechanical Thrombectomy in Acute Stroke: A Systematic Review and Meta-Analysis for Clinical and Radiological Outcomes.</article-title>
            <source>J Stroke</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>317</fpage>
            <page-range>317-323</page-range>
            <pub-id pub-id-type="pmid">33053947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez de la Ossa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abilleira</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jovin</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Tornel</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Urra</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cardona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cocho</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Purroy</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Serena</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>San Rom&#x000e1;n Manzanera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vivanco-Hidalgo</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Salvat-Plana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chamorro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gallofr&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cobo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Davalos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ribo</surname>
                <given-names>M</given-names>
              </name>
              <collab>RACECAT Trial Investigators</collab>
            </person-group>
            <article-title>Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>May</month>
            <day>10</day>
            <volume>327</volume>
            <issue>18</issue>
            <fpage>1782</fpage>
            <page-range>1782-1794</page-range>
            <pub-id pub-id-type="pmid">35510397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29570.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Man</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Saver</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Xian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Schwamm</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization.</article-title>
            <source>Stroke</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>412</fpage>
            <page-range>412-419</page-range>
            <pub-id pub-id-type="pmid">28008094</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
